Renal sympathetic denervation inhibites the development of left ventricular mechanical dyssynchrony during the progression of heart failure in dogs by unknown
CARDIOVASCULAR 
ULTRASOUND
Hu et al. Cardiovascular Ultrasound 2014, 12:47
http://www.cardiovascularultrasound.com/content/12/1/47RESEARCH Open AccessRenal sympathetic denervation inhibites the
development of left ventricular mechanical
dyssynchrony during the progression of heart
failure in dogs
Wei Hu1, Qing-yan Zhao2, Sheng-bo Yu3, Bin Sun1, Liao Chen1, Sheng Cao1 and Rui-qiang Guo1*Abstract
Background: The purpose of this study was to investigate whether transcatheter renal sympathetic denervation
(RSD) interfere with the development of left ventricular (LV) mechanical dyssynchrony during the progression of
heart failure (HF).
Methods: Nineteen beagles were randomly divided into sham-operated group (six dogs), control group (seven
dogs), and RSD group (six dogs). Sham-operated group were implanted with pacemakers without pacing; Control
group were implanted with pacemakers and underwent 3 weeks of rapid right ventricular pacing; and RSD group
underwent catheter-based RSD bilaterally and were simultaneously implanted with pacemakers. Both LV strain and LV
dyssynchrony were analyzed via 2D speckle-tracking strain echocardiography to evaluate LV function. Longitudinal
dyssynchrony was determined as the standard deviation for time-to-peak speckle-tracking strain on apical 4-
and 2-chamber views. Radial and circumferential dyssynchrony was determined as the standard deviation for
time-to-peak speckle-tracking strain in mid- and base-LV short-axis views. Each myocardial function was also evaluated
by averaging the peak systolic strains. LV systolic pressure (LVSP) and LV end-diastolic pressure (LVEDP) were measured.
The LV interstitial fibrosis was determined by histological analysis. Plasma angiotensin II (Ang II), aldosterone and
norepinephrine (NE) levels were also measured.
Results: After 3 weeks, all of the dogs in both the control and RSD groups showed greater LV end-diastolic volume
compared with the sham-operated group; however, the dogs in the RSD group had a higher LV ejection fraction (LVEF)
than the dogs in the control group (p < 0.001). The LV systolic strains were higher in the RSD group than in the control
group (p < 0.001 for longitudinal, circumferential and radial strain, respectively). The levels of LV dyssynchrony were
lower in the RSD group than in the control group (p < 0.001 for longitudinal, circumferential and radial dyssynchrony,
respectively). Compared with dogs with control alone, RSD dogs had lower LV end-diastolic pressures and less fibrous
tissue. The levels of plasma Ang II, aldosterone and NE were lower in the RSD group than in the control group.
Conclusions: RSD inhibites the development of left ventricular mechanical dyssynchrony during the progression
of heart failure in dogs.
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Heart failure (HF) is a major cause of morbidity and
mortality, and the epidemic of HF is an important public
health issue facing the health care system. Different
pathophysiologic mechanisms have been linked to the
development and propagation of HF. In cases of reduced
cardiac function, several compensation pathways are
activated to preserve cardiovascular homeostasis. One
of these mechanisms, which plays an essential role in
patients with HF, is governed by the neurohormonal
system, which consists of the sympathetic nervous sys-
tem (SNS) and the renin-angiotensin-aldosterone system
(RAAS) [1,2]. However, chronic activation of these
neurohormonal signals has deleterious effects on cardiac
structure and performance, leading to cardiac decom-
pensation and heart failure progression.
It was recently shown that left ventricular dyssyn-
chrony strongly correlates with the progression of HF
[3,4]. Dyssynchrony in the setting of HF is characterized
by nonsynchronous, abnormal electrical activation and an
abnormal contraction sequence [5]. More importantly,
previous studies have demonstrated that mechanical
dyssynchrony is strongly influenced by neurohormonal
activity, hemodynamic changes, LV heterogeneity, and
myocardial fibrosis [6-8].
The renal sympathetic nervous system has been identi-
fied as a major contributor to the complex pathophysi-
ology of both hypertension and HF in humans [9,10].
Animal studies have suggested that renal sympathetic
denervation (RSD) attenuates ventricular and electro-
physiological remodeling in animals with heart failure
[11-13]. Catheter-based RSD was recently introduced
as a technique that protects against heart failure via
denervation of efferent and afferent renal sympathetic
nerve fibers [14-16]. Following RSD, the activation of both
the SNS and RAAS is inhibited [17,18]. Other studies have
demonstrated that treatment with angiotensin-converting
enzyme (ACE) inhibitors diminish LV dyssynchrony
during the progression of pacing-induced HF, and beta-
blocker therapy stimulates increases in local contractility
and decreases in intraventricular dyssynchrony [6,19].
However, the relationship between RSD and LV dyssyn-
chrony remains unknown. Accordingly, the purpose of
the present study was to test the hypothesis that RSD
attenuates the impairment of LV mechanical dyssyn-
chrony during the progression of HF in dogs.
In recent years, various imaging techniques have been
tested to determine their ability to quantify LV dyssyn-
chrony, including magnetic resonance imaging, nuclear
imaging, and echocardiography [20-22]. The techniques
used most often have included echocardiography using
tissue Doppler imaging (TDI) and speckle tracking
strain analysis, which measures peak times in different
ventricular segments [22,23]. Furthermore, speckle trackingstrain analysis is based on grayscale 2-dimensional images,
which allow for the assessment of myocardial deformation
in 2 dimensions, including longitudinal strain (LS), which
represents myocardial shortening on the long-axis plane;
circumferential strain (CS), which represents myocardial
shortening on the short-axis plane; and radial strain (RS),




The study protocol was approved by the Ethical Com-
mittee of the Wuhan University School of Medicine, and
all animal handing was performed in accordance with the
Wuhan Directive for Animal Research and the current
Guidelines for the Care and Use of Laboratory Animals
published by the National Institutes of Health (NIH publi-
cation no.85-23, revised 1996). Nineteen beagles of both
sexes and approximately one year of age, weighing 13.4 ±
2.1 kg, were divided into the following three groups: 1) the
sham-operated group (n = 6); 2), the control group (n = 7);
and 3) the RSD group (n = 6). An intramuscular injection
of 25 mg/kg of ketamine sulphate was administered to all
the dogs. The dogs were then premedicated with pento-
barbital sodium (30 mg/kg IV; additional doses of 4 mg/kg
were administered when required throughout the experi-
ment), intubated, and ventilated using a respirator with
room air supplemented with oxygen (MAO01746; Harvard
Apparatus, Holliston, MA, USA). Continuous ECG moni-
toring was carried out using leads I, II and III.
The pacemakers (Shanghai Fudan University, China)
were implanted in a subcutaneous pocket and were
attached to a pacing lead (1646 T, St. Jude Medical, Inc,
USA) at the right ventricular apex (RVA), under fluoro-
scopic visualization via the right external jugular vein. In
the sham-operated group, when the surgery was com-
pleted, the dogs were allowed to recover for 3 weeks
without pacing. In the control group, after pacemaker
implantation, the dogs were allowed to recover for
3 days, and subsequently underwent rapid ventricular
pacing at 240 beats per minute (bpm) for 3 weeks. The
dogs in the RSD group underwent double renal artery
ablation prior to ventricular rapid pacing. A tailor-made
quadrupole radiofrequency ablation catheter was inserted
into each renal artery via femoral artery under fluoroscopy
(when the quadrupole ablation catheter was introduced
into each renal artery, each of the four tips was expanded
automatically and attached to the wall of the artery). We
applied radiofrequency ablations of 6 W or less and lasting
up to 90 sec within each renal artery. The catheter system
monitored tip temperature and impedance, altering radio-
frequency energy delivery in response to a predetermined
algorithm. In the sham-operated group and control group
dogs, the ablation catheter was inserted into each renal
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were implanted following ablation, and the dogs recovered
for 3 days and underwent pacing for 3 weeks.
Hemodynamic measurements
An 8 F sheath was inserted percutaneously in the right
femoral artery, through which a 5 F pigtail catheter
(Terumo) was introduced into the left ventricle through
the arterial sheath to detect LV systolic pressure (LVSP)
and LV end-diastolic pressure (LVEDP). The pressure
signals were continuously recorded and digitalized using
Lead 2000 multi-channel physiological signal recorder
(Sichuan Jinjiang Electronic Science and Technology
Co., Ltd, Sichuan, China).
Neurohormonal assays
After three weeks, 4 ml of venous blood was collected in
EDTA vacutainers and was centrifuged at 2,310 g for
10 min at 4°C (Avanti J-E; Beckman Coulter, Brea, CA,
USA). The serum was separated into microtubes and was
stored at −80°C until used for analysis. Plasma angiotensin
II (Canis Ang II Elisa Kit, Nanjing Jiancheng Bioengineering
Institute) and aldosterone (Canis Aldosterone Elisa Kit,
Nanjing Jiancheng Bioengineering Institute) concentra-
tions were both measured using ELISA. Plasma nor-
epinephrine (NE) concentrations were measured using
high-performance liquid chromatography [25,26].
Histological evaluation
At the completion of the protocol, the animals were
euthanized and the hearts were quickly excised. The
anterior wall of the left ventricle was dissected from the
heart and was immediately stored at −80°C. Masson’s
Trichrome staining was used to identify increased concen-
trations of interstitial fibrosis. Connective tissue was differ-
entiated on the basis of its color, and the levels were
expressed as percentages of reference tissue areas (Ti-S;
Nikon, Tokyo, Japan). Blood vessels and perivascular inter-
stitial cells were excluded from connective tissue quantifi-
cation. Ventricular interstitial collagen volume fractions
were determined by quantitative morphometry using an
image analyzer (IPP 6.0; Media Cybernetics, GA, USA).
Conventional echocardiography
All of the dogs underwent complete transthoracic echo-
cardiographic studies with 2-D, color flow and spectral
Doppler using a GE Vivid E9 system (GE Vingmed
Ultrasound As, Horten, Norway). Pulse wave Doppler
examinations of peak velocities of mitral inflow E and early
diastolic myocardial septal annulus movement velocities
(E’) were also recorded. LV end-diastolic volumes (LVEDV)
and end-systolic volumes (LVESV) were calculated from
apical views, using the modified Simpson method [27]. LV
stroke volume (SV) was calculated from the differencebetween LV end-diastolic and end-systolic volumes. LV
ejection fraction (EF) was calculated by dividing the
stroke volume by the LV end-diastolic volume [28].
2-D speckle tracking imaging of the left ventricle
Left ventricular strain and dyssynchrony were analyzed
via two-dimensional speckle tracking echocardiography,
using an ECHOPAC workstation as previously described
[29]. Routine two-dimensional images were obtained via
mid- and base-LV short-axis views and apical four- and
two-chamber views at rates of 40–60 frames/s. The
speckles of interest were followed throughout the entire
cardiac cycle, and myocardial longitudinal, radial and cir-
cumferential deformation was each calculated automatic-
ally. Longitudinal strain of the LV (LVLS) was calculated
as the average peak longitudinal strain across 12 segments
of apical four- and two-chamber views. LV circumferential
strain (LVCS) and LV radial strain (LVRS) were obtained
from 12 segments of mid- and base-LV short-axis views.
Mechanical dyssynchrony was assessed using the standard
deviations of the time from onset of the QRS interval to
the peak longitudinal strain of the LV (LV-Tls-12SD), the
peak radial strain of the LV (LV-Trs-12SD) and the peak
circumferential strain of the LV (LV-Tcs-12SD) (Figure 1).
The echocardiography was performed after turning off
the pacemaker. Digitally stored echocardiographic data
were analyzed by an experienced sonographer, and all of
the measurements represent an average of 3 to 5 con-
secutive cycles.
Statistical analysis
The data are presented as the means ± standard deviations.
For between-group changes, ANOVA with Newman-Keuls
tests was used to compare the means of continuous vari-
ables among multiple groups. In cases in which a significant
difference was found, further analysis was undertaken using
the Tukey-Kramer test. All of the statistical tests were
two sided, and a probability of p < 0.05 was required for
statistical significance (version 19.0 SPSS).
Results
Conventional echocardiography
Conventional echocardiographic images of all of the sub-
jects were successfully obtained and analyzed, and all of
the conventional echocardiographic characteristics of this
study are summarized in Table 1. The baseline measure-
ments (LVEDV, LVESV, LVEF, HR, LVEDP and LVSP)
among these three groups did not show significant
difference (data not shown). After 3 weeks, the dogs in
the RSD group demonstrated superior heart function
compared to the dogs in the control group, as evi-
denced by lower LVEDV and LVESV measurements,
higher LVSV and LVEF measurements, a lower mitral
E/E’ ratio and a higher systolic strain.
Figure 1 LV dyssynchrony in three directions (radial, circumferential and longitudinal) in the sham-operated group (sham), the
pacing-induced heart failure group (control), and the group treated with renal sympathetic denervation and rapid ventricular pacing
(RSD). LV mechanical dyssynchrony was assessed using the standard deviation of the time from onset of the QRS interval to peak strain.
Table 1 Routine echocardiographic and hemodynamic
characteristics
Sham Control RSD p
E (cm/s) 86.83 ± 2.32 72.00 ± 2.16* 77.50 ± 1.64*† 0.000
E’ (cm/s) 9.37 ± 0.52 4.96 ± 0.41* 6.39 ± 0.32*† 0.000
E/E’ 9.29 ± 0.40 14.58 ± 0.84* 12.16 ± 0.68*† 0.000
LVEDV (ml) 27.50 ± 1.05 35.86 ± 1.07* 31.50 ± 1.05*† 0.000
LVESV (ml) 9.17 ± 0.41 22.57 ± 0.98* 16.33 ± 0.52*† 0.000
LVSV (ml) 18.33 ± 0.82 13.29 ± 0.49* 15.17 ± 1.17*† 0.000
LVEF (%) 66.67 ± 1.08 37.07 ± 1.34* 48.10 ± 2.35*† 0.000
HR (beats/min) 110.17 ± 5.1 109.57 ± 3.1 106.17 ± 3.6 0.199
QRS duration (ms) 66.83 ± 2.86 67.29 ± 3.77 69.17 ± 2.40 0.404
LVEDP (mmHg) 5.5 ± 1.05 24.71 ± 2.14* 12.50 ± 1.05*† 0.000
LVSP (mmHg) 153.17 ± 4.07 124.71 ± 4.68* 130.83 ± 6.79* 0.000
Data are expressed as the means ± standard deviations; *p < 0.05 vs. the
sham-operated group; †p < 0.05 vs. the control group;E: mitral early diastolic
filling velocity; E’: mitral early diastolic annular velocity; LVEDV: left ventricular
end-diastolic volume; LVESV: left ventricular end-systolic volume; LVSV: left
ventricular stroke volume; EF: ejection fraction; HR: heart rate; LVEDP: left
ventricular end-diastolic pressure; LVSP: left ventricular systolic pressure.
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The peak times to left ventricular systolic strain were
not significantly different between the RSD group and
the control group (p > 0.05) (Table 2). In contrast, the
levels of longitudinal dyssynchrony, radial dyssynchrony
and circumferential dyssynchrony in the control group
were higher than those in the sham-operated group,
the differences were statistically significant (p < 0.001).
However, the levels of LV longitudinal, radial and cir-
cumferential dyssynchrony in the RSD group were
30.92 ± 2.34 ms, 36.42 ± 2.58 ms and 33.60 ± 1.94 ms,
respectively, which are significantly lower than those
in the control group (Figure 2).Table 2 Times to left ventricular peak systolic strain
Sham Control RSD p
LV-Tls (ms) 217.58 ± 11.31 238.39 ± 27.03 232.32 ± 14.74 0.182
LV-Tcs (ms) 214.56 ± 22.78 233.29 ± 16.52 223.63 ± 20.00 0.261
LV-Trs (ms) 217.85 ± 8.41 234.42 ± 16.49 226.03 ± 18.63 0.180
Data are expressed as the means ± standard deviations; LV: left ventricular; Tls:
time to peak longitudinal strain; Tcs: time to peak circumferential strain; Trs:
time to peak radial strain.
Figure 2 Left ventricular strain and dyssynchrony in three directions (longitudinal, radial and circumferential) in the sham-operated group
(sham), the pacing-induced heart failure group (control), and the group treated with renal sympathetic denervation and rapid ventricular
pacing (RSD). *p < 0.05 vs. the sham-operated group; †p < 0.05 vs. the control group. LV: left ventricular; RS: radial strain; CS: circumferential strain;
LS: longitudinal strain; SD: standard deviation.
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After the pacemakers were turned off for 30 min,
hemodynamic measurements were obtained. The LV sys-
tolic pressure (LVSP) was lower in the RSD group than
in the sham-operated group (130.83 ± 6.79 mm Hg vs.
153.17 ± 4.07 mm Hg, p < 0.001) but was not signifi-
cantly different from that in the control group. The LV
end-diastolic pressure (LVEDP) was lower in the RSD
group than in the control group (12.50 ± 1.05 mm Hg vs.
24.71 ± 2.14 mm Hg, p < 0.001), but it remained higher
than in the sham-operated group (p < 0.001) (Table 1).
Neurohormonal activity
The plasma angiotensin II (Ang II) levels were lower in
the RSD group compared with the control group (p < 0.05),
but they remained higher than those in the sham-operated
group (p < 0.05). The plasma aldosterone levels were signifi-
cantly lower in the RSD group compared with the control
group, but they remained higher than in the sham-operated
group (p < 0.05). The plasma norepinephrine levels were
significantly higher in the control group compared to
the sham-operated group, although they were slightly
attenuated in the RSD group (Figure 3).
Histological changes
Masson’s Trichrome staining was used to evaluate the
extent of fibrosis in each tissue section. Left ventricular
walls from each of the three groups were composed of
red myocardial tissue and blue collagen fibers (Figure 4).
Left ventricular images from the control group revealed a
large amount of fibrosis (24.2 ± 3.0%), whereas the sham-operated group demonstrated minimal fibrotic tissue
(4.4 ± 1.0%). In contrast, the RSD group demonstrated
significantly less fibrosis than the control group (8.5 ±
1.1% vs. 24.2 ± 3.0%, p < 0.05) (Figure 4).
Discussion
The major findings of our study were that RSD attenu-
ated the development of LV dyssynchrony after 3 weeks
rapid ventricular pacing and alleviated the activation of
neurohormonal signals.
Speckle-tracking echocardiography is an angle-
independent technique used to quantify myocardial
motion [24,30]. Previous studies have used this novel
method to evaluate LV dyssynchrony [31]. In the present
study, both left ventricular EF and systolic function were
reduced in the control group, suggesting that this HF
model was successful and was consistent with that of a
previous study [32]. Furthermore, RSD partially inhibited
the impairment of LV systolic function. Jialu Hu et al.
found that RSD had both preventive and therapeutic
effects on post-myocardial infarction cardiac remodeling
and that ejection fraction (EF) was partially protected by
RSD [11], consistent with the findings of our study. More
importantly, we found that the LV longitudinal, radial and
circumferential mechanical dyssynchronies were partially
inhibited by RSD.
HF is a clinical syndrome that develops in response to
an insult, resulting in a decline in the pumping capacity of
the heart. To compensate, neurohumoral mechanisms,
such as the SNS and RAAS, are activated [33]. These
systems initially compensate for depressed myocardial
Figure 3 Plasma angiotensin II, plasma aldosterone and plasma norepinephrine levels in the sham-operated group (sham), the
pacing-induced heart failure group (control), and the group treated with renal sympathetic denervation and rapid ventricular pacing
(RSD). *p < 0.05 vs. the sham-operated group; †p < 0.05 vs. the control group.
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However, their long-term activation has deleterious ef-
fects on cardiac structure and performance, leading
to myocardial remodeling, hemodynamic changes and
myocardial fibrosis [34,35].
LV mechanical dyssynchrony is strongly influenced by
hemodynamic changes (e.g., increases in preload and
afterload). Min-Seok et al. observed that nitroglycerin
improved LV mechanical dyssynchrony by reducing pre-
load. Conversely, the leg-raising maneuver significantly
elevated LV mechanical dyssynchrony by increasing pre-
load [36]. The E/E’ ratio, which represents the LV fillingFigure 4 Histological changes in the left ventricular tissues of the sha
(C). Summary of changes in the three groups (D). Red areas represent myocy
ventricular sections in the RSD group had less fibrosis than in the control groupressure, is correlated strongly with LV dyssynchrony
in hypertensive patients [37], indicating that preload
conditions are closely associated with LV dyssynchrony. In
the present study, the RSD group exhibited decreased
preload (LV end-diastolic pressure and LV end-diastolic
volume) compared to the control group, which might
have affected LV dyssynchrony. Miura et al. demon-
strated that impaired relaxation with afterload augmen-
tation induced by angiotensin II infusions caused LV
mechanical dyssynchrony [7], and Hyo et al. reported that
LV dyssynchrony was significantly affected by alterations
in LV end-systolic wall stress [38], suggesting thatm-operated group (A), the control group (B) and the RSD group
tes, and blue areas represent collagen (original magnification: 400). Left
p. *p < 0.05 vs. the sham-operated group; †p < 0.05 vs. the control group.
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dyssynchrony. However, in the present study, the after-
load (LV systolic pressure) was reduced in the RSD and
control groups compared with the sham-operated
group, showing that LV dyssynchrony is affected by
many factors.
The relationship between LV mechanical dyssyn-
chrony and myocardial fibrosis has been discussed.
Myocardial fibrosis can induce segmental wall asy-
nergy, leading to electrical and mechanical dyssyn-
chrony [39,40], and dyssynchronous wall motion is
more pronounced in patients with healed myocardial
infarctions [41]. Furthermore, both the location and the
extent of myocardial scarring are determinants of re-
sponsiveness to CRT because patients with transmural
scars at the location of the LV lead, as well as patients
with large areas of myocardial scarring, show lower
response rates to CRT compared to patients with min-
imal scar tissue [42-44]. In the present study, we found
that RSD inhibited the increasing of Ang II, aldos-
terone and norepinephrine, and the impairment of LV
fibrosis was sharply alleviated by RSD. So, RSD atte-
nuated the development of the ventricular remodeling
induced by long-term rapid ventricular pacing, consist-
ent with the findings of a previous study [39], sug-
gesting that RSD attenuate the development of left
ventricular dyssynchrony partly through the suppres-
sion of neurohormonal activation in the setting of
experimental HF.
Conclusion
Our study showed that RSD attenuates the development
of left ventricular dysfunction and dyssynchrony during
the progresses of HF partly by suppressing neurohor-
monal activation. Our findings suggested that RSD may
be a useful therapeutic method for the prevation and
treatment of LV dyssynchrony in the setting of HF.
Study limitations
This study had several limitations. First, two-dimensional
speckle tracking has several technical limitations be-
cause the accuracy of the strain values depends on the
quality of the images and the frame rates. Second, we
did not detect interventricular mechanical dyssynchrony.
Although interventricular mechanical dyssynchrony is
a strong predictor of cardiac function, there is no sim-
ple and reliable clinical method of measuring it. Third,
the effects of heart rate on mechanical dyssynchrony
might have confounded our results. In this study, de-
creasing trends in heart rate were noted in both the
control and RSD groups compared with the sham-
operated group, but no significant differences existed
among the groups. Fourth, RSD plays an important role
in regulating blood pressure, therefore, the protectiveeffect of RSD on cardiac function may be partially attri-
bute to the lowering effect of the blood pressure in this
study. But, the changes of blood pressure have not been
observed in three groups.
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